+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Smart Labels Market by Type of Technology, Type of Packaging, Type of Primary Packaging, Type of Secondary Packaging and Key Geographical Regions - Industry Trends and Global Forecasts, 2022-2035

  • PDF Icon

    Report

  • 175 Pages
  • December 2022
  • Region: Global
  • Roots Analysis
  • ID: 5707231

The annual market for counterfeit drugs is estimated to be USD 200 billion and this value is believed to be expanding rapidly. As per a report published by the World Health Organization (WHO), 20% of counterfeit pharmaceuticals include an incorrect amount of the active ingredient, while 30% of the counterfeit drugs contain no active ingredient at all. Such illegal practices are likely to endanger the lives of the patients, as well as tarnish the developer company's reputation. In order to overcome the aforementioned concerns, label service providers have strengthened the ongoing labelling practices and are shifting towards smart labelling technologies. A smart label comprises of printed information, a bar code identifier and a small transponder. This transponder contains a processing chip and an antenna that allows physical objects to communicate with the tag reader (for instance, RFID reader). Smart labels offer several benefits, such as tracing and tracking products in a supply chain, and tamper proofing, discouraging counterfeit drugs packaging. In this context, it is worth mentioning that the smart labelling technology is expected to save USD 0.8 - 1.5 million per year per company, through their applications in inventory management. Despite numerous growth drivers for adopting smart label technologies, there are some factors that may hinder the immediate uptake of smart label technologies. These include high price of integrating the technology as well as lack of well-established regulatory standards across the globe. Such considerations may also prevent investment opportunities for smart label technologies. It is worth highlighting that, in the recent years, consortiums, such as GS1 standards and RAIN Alliance, have been established to standardize global regulations. 

At present, various types of smart labels, including radio frequency identification device labels (RFID), internet of things (IoT) labels, bluetooth labels and others, are being deployed across various applications in the pharmaceutical and healthcare markets; these include supply chain management, asset tracking, patient tracking and clinical trial labelling. Currently, more than 90 companies are engaged in providing these labels for various applications. In addition, with an aim to diversify their area of application and enhance their existing product portfolios, players engaged in providing smart pharmaceutical and healthcare labels are actively collaborating with other industry stakeholders. It is also worth mentioning that over 400 patents related to smart labels have been filed / granted, highlighting the continuous pace of innovation in this field. Driven by the growing demand for authentic and efficient drugs and ongoing efforts of players to integrate sophisticated features in the product design and affiliated technology, the smart pharmaceutical and healthcare labels market is likely to witness noteworthy growth over the coming years.

Scope of the Report

The “Smart Labels Market (Pharmaceutical and Healthcare Labels) by Type of Technology (RFID, NFC and Other Technologies), Type of Packaging (Primary Packaging and Secondary Packaging), Type of Primary Packaging (Vials, Syringes, Cartridges, Ampoules, Bottles and Blister Packs), Type of Secondary Packaging (Boxes, Cartons and Pouches) and Key Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America) - Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of the current market landscape and future opportunities associated with the smart pharmaceutical and healthcare labels, offering in-depth analyses of the various business entities engaged in this domain, across different segments.

Amongst other elements, the report includes:

  • A brief overview of smart labels, along with the information on their role and advantages in healthcare sector, along with details on the types of smart labels, featuring their applications in the pharmaceutical and healthcare domain. In addition, it includes a discussion on various challenges associated with the adoption of smart labels, future perspectives, and the factors driving the smart pharmaceutical and healthcare labels industry.
  • A detailed review of the overall landscape of players engaged in the smart pharmaceutical and healthcare label providers domain, along with information on type of technology (including RFID labels, Bluetooth labels, sensing labels and IoT labels), RFID frequency band (low frequency, high frequency, NFC and ultra-high frequency and unspecified) and area(s) of application (supply chain management, asset tracking, patient centricity, patient tracking, payment tracking, product authentication, clinical trial labelling, blood bag management, other application(s))
  • A detailed competitiveness analysis of companies engaged in the development of smart pharmaceutical and healthcare labels, based on their supplier strength (in terms of years of experience and company size), service strength (based on the type of area(s) of application and type of RFID frequency band) and portfolio strength (in terms of number of technology).
  • Elaborate profiles of prominent players (shortlisted on the basis of number of application area and company size) that claim to specialize in offering smart pharmaceutical and healthcare labels. Each profile features a brief overview of the company, along with information on their year of establishment, number of employees, location of headquarters, key executives, as well as details related to their smart labels focused portfolio, recent developments and an informed future outlook.
  • An in-depth analysis of patents related to smart pharmaceutical and healthcare labels that have been filed / granted till date, based on several relevant parameters, such as type of patent, publication year, geographical location / patent jurisdiction, legal status, CPC symbols, type of industry, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents filed / granted in this industry.
  • A detailed analysis of the partnerships and collaborations inked in the domain, during the period 2018-2022, based on several parameters, such as year of partnership, type of partnership, most active player and region.
  • A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.
  • A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall smart pharmaceutical and healthcare labels market.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the smart pharmaceutical and healthcare labels market, over the coming years. We have provided informed estimates on the evolution of the market in the short to mid-term and mid to long term, for the period 2022-2035. Additionally, our year-wise projections of the current and future opportunity have been segmented based on relevant parameters, such as [A] type of technology (RFID Labels, NFC Labels and other Labels), [B] type of packaging (primary packaging and secondary packaging), [C] type of primary packaging (vials, syringes, cartridges, ampoules, bottles and blister packs), [D] type of secondary packaging (boxes, cartons and pouches) and [E] key geographical regions (North America, Europe, Asia Pacific, MENA and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

  • Who are the leading players engaged in the development of smart pharmaceutical and healthcare labels?
  • What is the relative competitiveness of different smart pharmaceutical and healthcare labels providers?
  • Which type of partnership models are most commonly being adopted by stakeholders engaged in this domain?
  • What are the key strategies that can be implemented by emerging players / start-ups to enter the highly competitive market for smart labels?
  • Which companies are actively filing patents to drive innovation in the field of smart pharmaceutical and healthcare labels?
  • What are the key challenges associated within the smart pharmaceutical and healthcare labels market?
  • What is the current / likely future market size of smart pharmaceutical and healthcare labels?

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines

2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
3.2.1 Types of Smart Labels
3.2.1.1. Radio Frequency Identification Device (RFID)
3.2.1.2. Near-Field Communication (NFC)
3.2.1.3. Internet of Things (IoT)
3.2.2. Need for Smart Labels in the Healthcare Sector
3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Technology
4.2.6. Analysis by Company Size and Type of Technology
4.2.7. Analysis by Type of RFID Frequency Band
4.2.8. Analysis by Area(s) of Application
4.2.9. Analysis by Company Size and Area(s) of Application
4.2.10. Analysis by Type of Technology and Area(s) of Application

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. CCL Industries
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Area(s) of Application
6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
6.3.1. Company Overview
6.3.2. Area(s) of Application
6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Area(s) of Application
6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
6.5.1. Company Overview
6.5.2. Area(s) of Application
6.5.3. Recent Developments and Future Outlook
6.6. SATO
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Area(s) of Application
6.6.4. Recent Developments and Future Outlook
6.7. Invengo
6.7.1. Company Overview
6.7.2. Area(s) of Application
6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
6.8.1. Company Overview
6.8.2. Area(s) of Application
6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
6.9.1. Company Overview
6.9.2. Area(s) of Application
6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
6.10.1. Company Overview
6.10.2. Area(s) of Application
6.10.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Publication Year and Type of Patent
7.3.3. Analysis by CPC Code
7.3.4. Analysis by Type of Applicant
7.3.5. Analysis by Geography
7.3.6. Analysis by Emerging Focus Areas
7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Most Active Players: Analysis by Number of Partnerships
8.3.4. Regional Analysis
8.3.4.1. Local and International Agreements
8.3.4.2. Intercontinental and Intracontinental Agreements

9. BLUE OCEAN STRATEGY
9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
9.2.1 Red Ocean
9.2.2 Blue Ocean
9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
9.2.4.1. Value Innovation
9.2.4.2. Strategy Canvas
9.2.4.3. Four Action Framework
9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
9.2.4.5. Six Path Framework
9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
9.2.4.7. Three Tiers of Noncustomers
9.2.4.8. Sequence of Blue Ocean Strategy
9.2.4.9. Buyer Utility Map
9.2.4.10. The Price Corridor of the Mass
9.2.4.11. Four Hurdles to Strategy Execution
9.2.4.12. Tipping Point Leadership
9.2.4.13. Fair Process
9.3. Concluding Remarks

10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035

11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors

12. CONCLUDING REMARKS13. APPENDIX I: TABULATED DATA14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Comparison of Radio Frequency Identification Device (RFID) and Near-Field Communication (NFC)
Figure 3.2 Advantages Offered by Smart Labels to Healthcare Industry
Figure 4.1 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Year of Establishment
Figure 4.2 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size
Figure 4.3 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Location of Headquarters
Figure 4.4 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology
Figure 4.6 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Type of Technology
Figure 4.7 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of RFID Frequency Band
Figure 4.8 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Area(s) of Application
Figure 4.9 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Area(s) of Application
Figure 4.10 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology and Area(s) of Application
Figure 5.1 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in North America
Figure 5.2 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in Europe
Figure 5.3 Company Competitiveness Analysis: Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific & RoW
Figure 6.1 CCL Industries: Annual Revenues, 2018 - H1 2022 (CAD Billion)
Figure 6.2 CCL Industries: Area(s) of Application
Figure 6.3 Schreiner: Area(s) of Application
Figure 6.4 Datalogic: Annual Revenues, 2018 - H1 2022 (EUR Billion)
Figure 6.5 Datalogic: Area(s) of Application
Figure 6.6 Tadbik: Area(s) of Application
Figure 6.7 SATO: Annual Revenues, FY 2018 - H1 2022 (JPY Billion)
Figure 6.8 SATO: Area(s) of Application
Figure 6.9 Invengo: Area(s) of Application
Figure 6.10 Intellhydro Technology: Area(s) of Application
Figure 6.11 RFiD Discovery: Area(s) of Application
Figure 6.12 ID Tech Solutions: Area(s) of Application
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2022
Figure 7.3 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 7.4 Patent Analysis: Distribution by CPC Symbols
Figure 7.5 Patent Analysis: Distribution by Type of Applicant
Figure 7.6 Patent Analysis: Distribution by Geography
Figure 7.7 Patent Analysis: Distribution by Emerging Focus Areas
Figure 7.8 Leading Industry Players: Distribution by Number of Patents
Figure 7.9 Patent Benchmarking: Distribution of Leading Industry Players by Patent Characteristics (CPC Symbols)
Figure 7.10 Patent Analysis: Distribution by Patent Age, 2015-2022
Figure 7.11 Patent Analysis: Categorizations based on Weighted Valuation Scores
Figure 7.12 Patent Analysis: Distribution by Patent Valuation
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend of Partnerships, 2018-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Most Active Players: Distribution by Number of Partnership Instances
Figure 8.5 Partnerships and Collaborations: Distribution by Local and International Agreements
Figure 8.6 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Figure 9.1 Red Ocean Strategy versus Blue Ocean Strategy
Figure 9.2 Blue Ocean Strategy: Strategy Canvas
Figure 9.3 Blue Ocean Strategy: Eliminate-Raise-Reduce-Create (ERRC) Grid
Figure 9.4 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map
Figure 9.5 Blue Ocean Strategy: Three Tiers of Noncustomers
Figure 9.6 Blue Ocean Strategy: Sequence of Blue Ocean Strategy
Figure 9.7 Blue Ocean Strategy: Buyer Utility Map
Figure 9.8 Blue Ocean Strategy: The Price Corridor of the Mass
Figure 10.1 Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035 (USD Billion)
Figure 10.2 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Technology, 2022-2035 (USD Million)
Figure 10.3 Smart Pharmaceutical and Healthcare Labels Market for RFID Labels, 2022-2035 (USD Million)
Figure 10.4 Smart Pharmaceutical and Healthcare Labels Market for NFC Labels, 2022-2035 (USD Million)
Figure 10.5 Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035 (USD Million)
Figure 10.6 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Packaging, 2022-2035 (USD Million)
Figure 10.7 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Primary Packaging, 2022-2035 (USD Million)
Figure 10.8 Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035 (USD Million)
Figure 10.9 Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035 (USD Million)
Figure 10.10 Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035 (USD Million)
Figure 10.11 Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035 (USD Million)
Figure 10.12 Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035 (USD Million)
Figure 10.13 Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035 (USD Million)
Figure 10.14 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Secondary Packaging, 2022-2035 (USD Million)
Figure 10.15 Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035 (USD Million)
Figure 10.16 Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035 (USD Million)
Figure 10.17 Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035 (USD Million)
Figure 10.18 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Geography, 2022-2035 (USD Million)
Figure 10.19 Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035 (USD Million)
Figure 10.20 Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035 (USD Million)
Figure 10.21 Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035 (USD Million)
Figure 10.22 Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035 (USD Million)
Figure 10.23 Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035 (USD Million)
Figure 11.1 SWOT Analysis: Harvey Ball Analysis
Figure 11.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 12.1 Concluding Remarks: Market Landscape
Figure 12.2 Concluding Remarks: Patent Analysis
Figure 12.3 Concluding Remarks: Partnerships and Collaborations
Figure 12.4 Concluding Remarks: Market Sizing and Opportunity Analysis (1/2)
Figure 12.5 Concluding Remarks: Market Sizing and Opportunity Analysis (2/2)

List Of Tables
Table 4.1 Smart Pharmaceutical and Healthcare Label Providers: List of Companies
Table 4.2 Smart Pharmaceutical and Healthcare Label Providers: Information on Type of RFID Frequency Band
Table 4.3 Smart Pharmaceutical and Healthcare Label Providers: Information on Area(s) of Application
Table 5.1 Company Competitiveness: Benchmarking the Capabilities of Leading Players
Table 6.1 CCL Industries: Company Overview
Table 6.2 CCL Industries: Recent Developments and Future Outlook
Table 6.3 Schreiner: Company Overview
Table 6.4 Schreiner: Recent Developments and Future Outlook
Table 6.5 Datalogic: Company Overview
Table 6.6 Datalogic: Recent Developments and Future Outlook
Table 6.7 Tadbik: Company Overview
Table 6.8 SATO: Company Overview
Table 6.9 SATO: Recent Developments and Future Outlook
Table 6.10 Invengo: Company Overview
Table 6.11 Invengo: Recent Developments and Future Outlook
Table 6.12 Intellhydro Technology: Company Overview
Table 6.12 RFiD Discovery: Company Overview
Table 6.13 RFiD Discovery: Recent Developments and Future Outlook
Table 6.14 ID Tech Solutions: Company Overview
Table 7.1 Patent Analysis: Top CPC Sections
Table 7.2 Patent Analysis: Top CPC Symbols
Table 7.3 Patent Analysis: Top CPC Codes
Table 7.4 Patent Analysis: Summary of Benchmarking
Table 7.5 Patent Analysis: List of Leading Patents (by Highest Relative Valuation)
Table 8.1 Smart Pharmaceutical and Healthcare Labels: List of Partnerships and Collaborations
Table 10.1 Average Prices of Primary Packaging Containers and Secondary Packaging Containers
Table 13.1 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Year of Establishment
Table 13.2 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size
Table 13.3 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Location of Headquarters
Table 13.4 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Location of Headquarters
Table 13.5 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology
Table 13.6 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Company Size and Type of Technology
Table 13.7 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of RFID Frequency Band
Table 13.8 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Area(s) of Application
Table 13.9 Smart Pharmaceutical and Healthcare Label Providers: Distribution Company Size and Area(s) of Application
Table 13.10 Smart Pharmaceutical and Healthcare Label Providers: Distribution by Type of Technology and Area(s) of Application
Table 13.11 CCL Industries: Annual Revenues, 2018 - H1 2022 (CAD Billion)
Table 13.12 Datalogic: Annual Revenues, 2018 - H1 2022 (EUR Billion)
Table 13.13 SATO: Annual Revenues, FY 2018 - H1 FY 2022 (JPY Billion)
Table 13.14 Patent Analysis: Distribution by Type of Patent
Table 13.15 Patent Analysis: Cumulative Distribution by Publication Year, 2015-2022
Table 13.16 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 13.17 Patent Analysis: Distribution by Type of Applicant
Table 13.18 Patent Analysis: Distribution by Geography
Table 13.19 Leading Industry Players: Distribution by Number of Patents
Table 13.20 Patent Analysis: Distribution by Patent Age, 2015-2022
Table 13.21 Partnerships and Collaborations: Distribution by Cumulative Year-wise Trend of Partnerships, 2018-2022
Table 13.22 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.23 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.24 Most Active Players: Distribution by Number of Partnership Instances
Table 13.25 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 13.26 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Table 13.27 Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035 (USD Billion)
Table 13.28 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Technology, 2022-2035 (USD Million)
Table 13.29 Smart Pharmaceutical and Healthcare Labels Market for RFID Labels, 2022-2035 (USD Million)
Table 13.30 Smart Pharmaceutical and Healthcare Labels Market for NFC Labels, 2022-2035 (USD Million)
Table 13.31 Smart Pharmaceutical and Healthcare Labels Market for Other Labels, 2022-2035 (USD Million)
Table 13.32 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Packaging, 2022-2035 (USD Million)
Table 13.33 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Primary Packaging, 2022-2035 (USD Million)
Table 13.34 Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035 (USD Million)
Table 13.35 Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035 (USD Million)
Table 13.36 Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035 (USD Million)
Table 13.37 Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035 (USD Million)
Table 13.38 Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035 (USD Million)
Table 13.39 Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035 (USD Million)
Table 13.40 Smart Pharmaceutical and Healthcare Labels Market: Distribution by Type of Secondary Packaging, 2022-2035 (USD Million)
Table 13.41 Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035 (USD Million)
Table 13.42 Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035 (USD Million)
Table 13.43 Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035 (USD Million)
Table 13.44 Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035 (USD Million)
Table 13.45 Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035 (USD Million)
Table 13.46 Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035 (USD Million)
Table 13.47 Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035 (USD Million)
Table 13.48 Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035 (USD Million)
Table 13.49 Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACURA Technologies
  • Adilam
  • Alien Technology
  • All4Labels
  • Althea
  • Apitrak
  • Avery Dennison
  • Biolog-id
  • BIXOLON
  • Bluebird
  • BluEpyc
  • BSN
  • Cadi Scientific
  • CCL Industries
  • CenTrak
  • Covectra
  • CYBRA
  • Cypheme
  • Datalogic
  • DeRoyal
  • Dialoc ID
  • Dipole RFID
  • eAgile
  • Easitag
  • Electro-Com
  • e-TAG RFID
  • Faller
  • Faubel
  • Fedrigoni
  • Findaa Technology
  • FineLine Technologies
  • Fresenius Kabi
  • GAO RFID
  • George Schmitt & Co
  • Govplace
  • GuardRFID
  • Health Care Logistics
  • HID Global
  • Hoxworth Blood Center
  • HUAYUAN
  • ID Integration
  • ID Tech Solutions
  • Identiv
  • iDTRONIC
  • Impinj
  • IndustriTAG
  • INFORMS
  • Intellhydro Technology
  • Intelligent Label Solutions
  • IntelliGuard
  • Invengo
  • Invison Technology
  • Kit Check
  • Label Logic
  • LabTAG
  • Laxcen Technology
  • Long Beach Medical Center
  • LUX-IDent
  • MDT Innovations
  • Metalcraft
  • MPI Label Systems
  • MSM Solutions
  • Multi-Color Corporation (MCC)
  • Murata
  • NL Technologies
  • NXP Pharmaceuticals
  • Omnia Technologies
  • Omnicell
  • Omni-ID
  • OSRFID
  • Paragon ID
  • PDi Digital
  • PervasID
  • Point Mobile
  • PragmatIC
  • Presco
  • Pycube
  • Quanray Electronics
  • Resource Label
  • RFID Canada
  • RFiD Discovery
  • RFID4U
  • RFRain
  • RMS Omega
  • SAG (Securitag Assembly Group)
  • Sandoz
  • SATO Asia Pacific
  • SBS Consultores
  • Schreiner
  • Seagull Scientific
  • Skanem
  • Smartrac
  • SmartX Technology
  • SML Group
  • Spacecode Technologies
  • Tadbik
  • Tageos
  • Talkin' Things
  • TechSigno
  • Tego
  • Terso Solutions
  • The Barcode Warehouse
  • tracekey
  • TruTag Technologies
  • Turck
  • United Ad Label
  • VerifyMe
  • VisionID
  • Vizinex RFID
  • Vizzia Technologies
  • White
  • Wiliot
  • William Frick & Company
  • Winnix Technologies
  • worX Software
  • Xerafy
  • Zebra Technologies

Methodology

 

 

Loading
LOADING...